Follicular lymphoma (FL) accounts for 10–15% of non-Hodgkin’s lymphomas in western countries. Although patients with FL experience a relatively indolent course and usually exhibit dramatic responses to initial therapy, they should be considered affected by a fatal malignancy. There is a tendency to relapse over time, the response to salvage treatments is of shorter duration after every relapse, and patients eventually die of disease-related causes. Several treatment approaches are offered to patients with FL; however, criteria to rationalize treatment decisions are still lacking in many instances.

The prognosis of follicular lymphomas: The F2-project / Federico, Massimo; Bellei, Monica; Pro, B.; Lopez Guillermo, A.; Vitolo, U.; Luminari, Stefano; Pileri, S.; Solal Céligny, P.. - In: HAEMATOLOGICA REPORTS. - ISSN 1824-9337. - STAMPA. - 2 (7)(2006), pp. 44-47.

I documenti presenti in Iris Unimore sono rilasciati con licenza Creative Commons Attribuzione - Non commerciale - Non opere derivate 3.0 Italia, salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Powered by IRIS-about IRIS-Utilizzo dei cookie

 Copyright © 2021